Article Text

Download PDFPDF

2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort
Free
  1. Adrien Boscher1,
  2. Emilie Bogart2,
  3. Mehdi Benna1,
  4. Camille Pasquesoone3,
  5. Houssein El Hajj1,
  6. Delphine Hudry1,
  7. Helene Gauthier4,
  8. Julien Brochet5,
  9. Valerie Chevalier-Evain6,
  10. Florence Le Tinier7,
  11. Eric Leblanc1,
  12. Marie Cecile Le Deley2,
  13. Fabrice Narducci1,
  14. Abel Cordoba7 and
  15. Carlos Martinez Gomez1
  1. 1Department of Surgical Oncology, Centre Oscar Lambret, Lille, France
  2. 2Department of Statistics and Medical Research, Centre Oscar Lambret, Lille, France
  3. 3Department of Pathology, Centre Oscar Lambret, Lille, France
  4. 4Department of Nuclear Medicine, Centre Oscar Lambret, Lille, France
  5. 5Department of Imaging, Centre Oscar Lambret, Lille, France
  6. 6Department of Medical Oncology, Centre Oscar Lambret, Lille, France
  7. 7Department of Radiotherapy, Centre Oscar Lambret, Lille, France

Abstract

Introduction/Background Lymph node involvement in locally advanced cervical cancer impacts survival and defines radiation fields. False negatives (FN) of Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in the aortic region represent a limitation of this technique. It may lead to undertreatment of metastatic aortic lymph nodes. In selected cases, aortic lymph node staging can be considered to catch up the FN to tailor radiation fields. The aim was to analyze metastatic aortic lymph status according to FIGO 2009 classification and pelvic lymph node status.

Methodology From 01/2009 to 12/2019, we retrospectively reviewed all consecutive patients (pts) addressed for brachytherapy diagnosed with locally advanced cervical cancer FIGO 2009 stages IB2-IVa with negative PET-CT uptake in the aortic area and histologic lymph node involvement after surgical staging.

Results Of 178 pts who underwent surgical staging, metastatic aortic lymph nodes were found in 26 cases (FN rate=14,6%). Among these 26 pts, 12 (46%) did not show pelvic TEP-CT uptake, while 14 (54%) did. FIGO 2009 stages was IB2-II for 5 pts (19%), stage III for 20 pts (77%) and stage IV for 1 pt (4%). When analyzing pts with metastatic pelvic nodes, determined with preoperative PET-CT and FIGO 2009 staging system, aortic involvement was found in 4/5 pts (80%) of stages IB2-II and 10/20 pts (50%) of stages III.

Conclusion Aortic lymph node dissection is helpful to optimize radiation therapy fields in locally advanced cervical cancer. Pts with stages III and IV and those with stage Ib2-II and positive pelvic lymph seems to present the highest risk of occult aortic involvement. Aortic staging may be omitted in pts with stages Ib2-II without pelvic nodes as the risk of aortic involvement remains low.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.